• Explore /
  • Poster
  • / Germline polymorphisms in genes maintaining replication fork to predict the efficacy of oxaliplatin and irinotecan in metastatic colorectal cancer (mCRC) patients enrolled in MAVERICC trial.

Germline polymorphisms in genes maintaining replication fork to predict the efficacy of oxaliplatin and irinotecan in metastatic colorectal cancer (mCRC) patients enrolled in MAVERICC trial.

Abstract Poster

Authors

null

Hiroyuki Arai

Division of Medical Oncology, USC Norris Comprehensive Cancer Center, Keck School of Medicine, Los Angeles, CA

Hiroyuki Arai , Yi Xiao , Jingyuan Wang , Francesca Battaglin , Natsuko Kawanishi , Priya Jayachandran , Shivani Soni , Zhang Wu , Christoph Mancao , Bodour Salhia , Shannon M. Mumenthaler , Joshua Millstein , Heinz-Josef Lenz

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2021 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Developmental Therapeutics—Molecularly Targeted Agents and Tumor Biology

Track

Developmental Therapeutics—Molecularly Targeted Agents and Tumor Biology

Sub Track

Other Developmental Therapeutics

Citation

J Clin Oncol 39, 2021 (suppl 15; abstr 3139)

DOI

10.1200/JCO.2021.39.15_suppl.3139

Abstract #

3139

Poster Bd #

Online Only

Abstract Disclosures

Similar Posters

First Author: Hiroyuki Arai

First Author: Pooja Mittal

First Author: Jingyuan Wang

First Author: Yuki Matsubara